/NanHua Bio-medicine CO., Ltd signed a cooperation agreement with the National Stem Cell Transformation Resource Bank to jointly build the "National Stem Cell Transformation Resource Bank Hunan Clinical Research Center"

NEWS

NanHua Bio-medicine CO., Ltd signed a cooperation agreement with the National Stem Cell Transformation Resource Bank to jointly build the "National Stem Cell Transformation Resource Bank Hunan Clinical Research Center"

NanHua Bio-medicine CO.,Ltd

2022/01/11

Category: Company News
Author: NanHua Bio-medicine CO.,Ltd
Source: NanHua Bio-medicine CO.,Ltd
Release time: 2022-01-11 13:46
Number of visits:

Category: Company News
Author: NanHua Bio-medicine CO.,Ltd
Source: NanHua Bio-medicine CO.,Ltd
Release time: 2022-01-11 13:46
Number of visits:

Details

NanHua Bio-medicine CO.,Ltd signed a joint construction agreement with the National Stem Cell Transformation Resource Bank

"National Stem Cell Transformation Resource Bank Hunan Clinical Research Center" Cooperation Agreement

*The launch ceremony of the National Stem Cell Transformation Resource Library Hunan Clinical Research Center

On January 10, 2022, the National Stem Cell Transformation Resource Bank and NanHua Bio-medicine CO., Ltd., a state-owned main board listed company, signed a cooperation agreement to jointly build the "National Stem Cell Transformation Resource Bank Hunan Clinical Research Center". The two parties will focus on the preservation and transformation application of stem cell resources, carry out in-depth cooperation in basic research, clinical research, disease treatment, creative innovation and other directions, conduct collaborative innovative research and comprehensive open sharing, and lead the breakthrough development in the field of life sciences in Hunan. Chen Danping, Secretary of the Party Leadership Group, Executive Vice President and First-Class Inspector of the Red Cross Society of Hunan Province, Wang Tize, Deputy Secretary-General of the Changsha Municipal People’s Government, Liu Zhongmin, Director of the Clinical Grade Stem Cell Resource Bank of the National Stem Cell Transformation Resource Bank and Director of the Oriental Hospital Affiliated to Tongji University, Dai Helong, Vice President of the Red Cross Society of Hunan Province, Associate Researcher at the Second Xiangya Hospital of Central South University, Deputy Director of the Hunan Provincial Organ Transplantation Clinical Medical Research Center, Li Fankun, Party Secretary and Vice Chairman of Changsha Science and Technology Association, Li Pingbo, Member of the Party Working Committee and First-level Investigator of Changsha High-tech Zone, Yang Yun, Chairman of NanHua Bio-medicine CO., Ltd., NanHua Bio-medicine You Changqiao, director and general manager of CO., Ltd. Pharmaceutical Co., Ltd., and other leading guests attended this event.

Opening

Yang Yun, Chairman of NanHua Bio-medicine CO., Ltd.

"Integrating superior resources to promote a new leap in health care"

*Yang Yun, Chairman of NanHua Bio-medicine CO., Ltd., delivered a welcome speech

Yang Yun, Chairman of NanHua Bio-medicine CO., Ltd., said that the launch of the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank will give full play to the advantages of the National Stem Cell Transformation Resource Bank in stem cell storage, production and preparation, drug research, clinical application and other aspects and the leadership of the stem cell industry. Relying on NanHua Bio-medicine CO., Ltd.’s stem cell research foundation and achievements in Hunan are based on becoming a national benchmark and demonstration for the clinical application and transformation of regional stem cell resources, and effectively promote the sustainable development of stem cell regenerative medicine technology and stem cell industrialization. NanHua Bio-medicine CO., Ltd. will focus on strategic goals, integrate resources from all parties, and intensively cultivate the biotechnology industry in the "specialized and new" field of stem cells to promote a new leap in human health.

Li Pingbo, member of the Party Working Committee of Changsha High-tech Zone and first-level researcher

"Build an innovative city and promote the construction of a scientific and technological innovation highland"

*Li Pingbo, member of the Party Working Committee of Changsha High-tech Zone and first-level researcher, delivered a speech

Li Pingbo, member of the Party Working Committee and first-level researcher of Changsha High-tech Zone, said that the establishment of the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank in Changsha High-tech Zone is a concrete practice to implement the strategy of strengthening the provincial capital proposed by the Party Congress, support Changsha in building an innovative city, and explore new paths for the development of Hunan's characteristic biopharmaceutical industry. The launch of the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank is an important milestone in the construction of the biomedical industry cluster in Changsha High-tech Zone, and is also a landmark achievement in fully promoting the construction of a scientific and technological innovation highland.

Liu Zhongmin, head of the clinical-grade stem cell resource bank of the National Stem Cell Transformation Resource Bank and president of Dongfang Hospital Affiliated to Tongji University

"Leveraging platform advantages to build stem cell territory"

*Liu Zhongmin, head of the clinical-grade stem cell resource bank of the National Stem Cell Transformation Resource Bank and president of the Oriental Hospital Affiliated to Tongji University, delivered a speech

Liu Zhongmin, head of the clinical-grade stem cell resource bank of the National Stem Cell Transformation Resource Bank and president of Dongfang Hospital affiliated to Tongji University, said that the launch of the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank was the high recognition and top-level planning of the development of social medicine by Hunan Province, Changsha City and Changsha Economic Development Zone. Although stem cells are still in the clinical research stage at present, in the future this is a new technology that can subvert traditional medical treatments. It can be said that Hunan has already seen the dawn. Shanghai Oriental Hospital Affiliated to Tongji University has a complete overall layout from basic research to clinical research and industrialization in the field of stem cells, and has multiple provincial and ministerial-level stem cell public service platforms. This means that our responsibility is not only to carry out basic research and the structure of the stem cell industry chain in Shanghai, but more importantly, to export and cooperate with these technologies and some product results to other brother provinces and municipalities. For stem cells to eventually be recognized by everyone and become our hope for clinical treatment of patients, it actually requires efforts from all aspects. We hope that through today's cooperation with NanHua Bio-medicine CO., Ltd., we can be at the forefront of stem cell clinical research in the country.

Zhou Honghao, academician of the Chinese Academy of Engineering and pharmacogenetic and clinical pharmacologist

“We must make full use of scientific research resources and develop innovative scientific research results.”

Signing Ceremony

*National Stem Cell Transformation Resource Bank Hunan Clinical Research Center Signing Ceremony

Witnessed by Chen Danping, Secretary of the Party Leadership Group, Executive Vice President, and First-Class Inspector of the Hunan Provincial Red Cross Society, Wang Tize, Deputy Secretary-General of the Changsha Municipal People's Government, Li Fankun, Secretary of the Party Leadership Group and Vice Chairman of Changsha Science and Technology Association, Li Pingbo, Member of the Party Working Committee of Changsha High-tech Zone, and First-Class Investigator, Liu Zhongmin, Director of the Clinical Stem Cell Resource Bank of the National Stem Cell Transformation Resource Bank and Dean of the Oriental Hospital Affiliated to Tongji University, NanHua Bio-medicine You Changqiao, director and general manager of CO., Ltd. Pharmaceutical Co., Ltd., and Zhang Shengbiao, chairman of Xinzhongshen (Shenzhen) Health Technology Services Co., Ltd., signed the "Co-construction of the National Stem Cell Transformation Resource Bank Hunan Clinical Research Center" project.

*Liu Lipeng, President of Changsha Economic Development Hospital (second from right), Zhang Hongming, General Manager of the Public Affairs Department of NanHua Bio-medicine CO., Ltd. (first from right), Guangzhou Mei Han (first from left), general manager of Sainz Pharmaceutical Technology Co., Ltd., signed a contract to jointly build a clinical research base for stem cell drugs in Hunan Province. Chen Danping (third from left), party secretary, executive vice president and first-level inspector of Hunan Red Cross Society; Wang Tize (fourth from left), deputy secretary-general of Changsha Municipal People's Government; Li Fankun (second from left), party secretary and vice chairman of Changsha Science and Technology Association; Li Pingbo (third from right), member of the Party Working Committee of Changsha High-tech Zone and first-level researcher, witnessed the signing

The second round of signings was between Changsha Economic Development Hospital and NanHua Bio-medicine CO., Ltd. to jointly build a clinical research base for stem cell drugs in Hunan Province. The establishment of the base will focus on drug development, achievement transformation and data sharing of biological sample resources, accelerate the integration of scientific research institutions, clinical practice, public health and industry, promote the scientific protection and efficient use of biological sample resources, maintain biological safety, promote independent innovation in biotechnology, and become a powerful engine for the high-quality development of Hunan's biomedical industry chain.

Unveiling Ceremony

*The picture shows Zhang Shengbiao, Chairman of Xinzhongshen (Shenzhen) Health Technology Services Co., Ltd. (first from the left), Liu Zhongmin, director of the clinical-grade stem cell resource bank of the National Stem Cell Transformation Resource Bank and President of Tongji University Affiliated Oriental Hospital, "middle", and You Changqiao, director and general manager of NanHua Bio-medicine CO., Ltd. (first from the right), unveiling the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank.

The National Stem Cell Transformation Resource Bank, Xinzhongshen (Shenzhen) Health Technology Services Co., Ltd. and NanHua Bio-medicine CO., Ltd. completed the unveiling ceremony of the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank.

It is understood that the National Stem Cell Transformation Resource Bank is approved by the Ministry of Science and Technology and is one of only two national-level stem cell banks in the country. It belongs to the basic support and condition guarantee base among the three major categories of national science and technology innovation bases. It is at the same level as the National Key Laboratory and the National Engineering Research Center. The establishment of the Hunan Clinical Research Center (including a non-human primate experimental base) by the National Stem Cell Transformation Resource Bank in Changsha High-tech Zone is based on the foundation and results of stem cell research of NanHua Bio-medicine CO., Ltd. in Hunan. It will further leverage the leading advantages of the National Stem Cell Transformation Resource Bank in the stem cell industry, standardize and establish national standards for the clinical application and transformation of regional stem cell resources. At the same time, the center will also focus on major national development strategies, cooperate with advanced scientific research institutions at home and abroad to carry out scientific and technological research and development in the field of stem cells, apply domestic and foreign stem cell innovative results to my country's health and medical field, and strive to build an integrated innovation platform for stem cell transformation that covers basic stem cell research, clinical scientific research, and related product transformation, application development and promotion.

*He Jun (middle), deputy director of Changsha Maternal and Child Health Hospital, Hu Xiang (first from right), associate professor of Hunan Normal University, and Wu Le (first from left), general manager of Hunan Boai Kangmin Stem Cell Tissue Engineering Co., Ltd., unveiled the "Stem Cell Regenerative Medicine and Reproductive Health" industry-university-research cooperation demonstration base

Then the unveiling ceremony of the "Stem Cell Regenerative Medicine and Reproductive Health" industry-university-research cooperation demonstration base was held.

Issue letter of appointment

*Liu Zhongmin, head of the clinical-grade stem cell resource bank of the National Stem Cell Transformation Resource Bank and president of Tongji University Affiliated Dongfang Hospital, "middle" presented to Zhou Honghao, academician of the Chinese Academy of Engineering, pharmacogenetics and clinical pharmacologist (Academician Zhou was unable to attend due to work reasons, and Fang Jincheng, general manager of strategic cooperation of NanHua Bio-medicine CO., Ltd., took the lead on his behalf ("first from the right"), NanHua Bio-medicine You Changqiao, Director and General Manager of CO.,Ltd Pharmaceutical Co., Ltd. (first from the left) issues the letter of appointment

At this event, the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank hired Zhou Honghao, an academician of the Chinese Academy of Engineering, pharmacogenetics and clinical pharmacologist, as the honorary director, and You Changqiao, director and general manager of NanHua Bio-medicine CO., Ltd., as the deputy director. Liu Zhongmin, head of the clinical-grade stem cell resource bank of the National Stem Cell Transformation Resource Bank and president of the Oriental Hospital Affiliated to Tongji University, personally issued the letter of appointment.

Leadership speech

Wang Tize, Deputy Secretary-General of Changsha Municipal People’s Government

"Create a resource pool, innovate service mechanisms, and implement the "three highs and four new" strategy"

*Speech by Wang Tize, Deputy Secretary-General of Changsha Municipal People’s Government

Wang Tize, deputy secretary-general of the Changsha Municipal People's Government, pointed out in his speech that the biomedicine (gene technology) industry chain is one of the 22 emerging and advantageous industrial chains that Changsha City focuses on developing. Currently, the Changsha Municipal Party Committee and Municipal Government are guided by the spirit of General Secretary Xi Jinping's series of important speeches on Hunan work, vigorously implementing the "three highs and four new" strategy, and comprehensively building a modern new Changsha. The signing of this contract to cooperate in the construction of the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Library and the creation of a third-party service system for the stem cell industry will be conducive to promoting the superior resources in the biomedicine field, the gathering of high-end talents and the transformation of scientific and technological innovation achievements. It will greatly promote the construction of the Changsha National Science and Technology Innovation Center, which is of great significance and far-reaching influence. In the future, it is hoped that the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank can innovate the service mechanism, create a personalized, flexible, standardized and shared resource pool, adhere to the strategic goal of "domestic first, international first-class", become a benchmark and demonstration for third-party human genetic resource sample banks, give full play to the demonstration and leading role of the innovation platform, vigorously promote the high-quality development of the biomedical technology industry, and make Changsha's due contribution to the construction of the province's biomedical technology innovation cluster.

Chen Danping, Secretary of the Party Leadership Group, Executive Vice President, and First-Class Inspector of the Red Cross Society of Hunan Province

"Strategic coordinated development to promote the high-quality development of the stem cell industry"

*Chen Danping, Secretary of the Party Leadership Group, Executive Vice President, and First-Class Inspector of the Red Cross Society of Hunan Province, delivered a speech

In her speech, Chen Danping, Secretary of the Party Leadership Group, Executive Vice President and First-Class Inspector of the Hunan Provincial Red Cross Society, pointed out that stem cell technology, as the most cutting-edge scientific field, is one of the strategic emerging industries focused on the development of the country. Last year, the Hunan Provincial People's Government issued "Several Opinions on Promoting the Innovation and Development of the Biomedical Industry", which mentioned that "it is necessary to support a number of high-quality stem cell and regenerative medicine enterprises and gradually build an innovation and industrial chain integrating cell storage - cell production and preparation - cell drug research and development and clinical technology research - cell clinical treatment." This marks that the stem cell industry in Hunan Province is about to usher in new historical development opportunities. It is hoped that in the future, the Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank and the National Stem Cell Bank will be closely connected and develop collaboratively, and with the help of the top scientific research power and superior resources of the national platform, it will further promote the Hunan regional stem cell industry to achieve new breakthroughs in clinical research and scientific research technology, and take solid steps to promote regional stem cell regenerative medicine technology innovation and the high-quality development of stem cell industrialization.

Conclusion

As an important biological resource for human beings, stem cells have become one of the most promising directions in international life science research in the 21st century. NanHua Bio-medicine CO., Ltd. has currently established strategic partnerships with a number of scientific research institutions, universities, medical institutions, enterprises and social teams. In the future, NanHua Bio-medicine CO., Ltd will give full play to the advantageous background of a state-owned main board listed company and actively build an innovative cell industry ecosystem that integrates "government, industry, academia, research, medicine and capital". At the same time, it will make good use of the platform of the National Stem Cell Transformation Resource Bank Hunan Clinical Research Center to closely connect with the National Stem Cell Bank and develop collaboratively. It adheres to the principle of people first and life first, adheres to the strategic goal of "internationally advanced, domestically leading", and leverages the top scientific research power and advantages of the national platform. resources, jointly promote the innovative development of the national stem cell biological industry chain and treatment, further enhance the innovation power and achievement transformation power of stem cell clinical research, further promote the national stem cell industry clinical research and scientific research technology to achieve new breakthroughs, strive to make the National Stem Cell Transformation Resource Bank Hunan Clinical Research Center a benchmark and demonstration for the cell industry in the central region, inject new impetus into the national stem cell regenerative medicine technology innovation, and jointly assist the high-quality and sustainable development of the national life and health industry.

Keywords:

Previous: The Hunan Clinical Research Center of the National Stem Cell Transformation Resource Bank hired Academician Zhou Honghao as the Honorary Director Next: NanHua Bio-medicine CO.,Ltd held the 2021 year-end summary meeting and 2022 work planning meeting